UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000016739 |
|---|---|
| Receipt number | R000019428 |
| Scientific Title | Investigation into the specific brain network of with anti tumor agents by functional MRI |
| Date of disclosure of the study information | 2015/03/31 |
| Last modified on | 2022/09/14 14:48:28 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation into the specific brain network of with anti tumor agents by functional MRI
Acronym
Investigation into the specific brain network of with anti tumor agents by functional MRI
Scientific Title
Investigation into the specific brain network of with anti tumor agents by functional MRI
Scientific Title:Acronym
Investigation into the specific brain network of with anti tumor agents by functional MRI
Region
| Japan |
Condition
Condition
lung cancer, breast cancer
Classification by specialty
| Chest surgery | Breast surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Investigation into treatment for patients given bevacizumab with lung or breast cancer an outbreak of cerebral vessel disorders
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Investigation of side effects by anti tumor agents
Key secondary outcomes
Concentrations of VEGF
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | < |
Age-upper limit
| 90 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Treatment with anti tumor agents.
Ability to informed consent.
Key exclusion criteria
Devices of like pacemakers , plates, artificial joints.
Claustrophobia.
Disorders of audition.
Cerebral vessels disorders.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | RIKA NOGAWA |
Organization
Wakayama medica school
Division name
Anesthegiology
Zip code
Address
811-1, Kimiidera, Wakayama-city, Wakayama JAPAN
TEL
073-447-2300
rikan@wakayama-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | RIKA NOGAWA |
Organization
Wakayama medical school
Division name
Anesthegiology
Zip code
Address
811-1, Kimiidera, Wakayama-city, Wakayama JAPAN
TEL
073-447-2300
Homepage URL
rikan@wakayama-med.ac.jp
Sponsor or person
Institute
Wakayama medical School
Institute
Department
Personal name
Funding Source
Organization
Wakayama medical school
Organization
Division
Category of Funding Organization
Local Government
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 03 | Month | 31 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2014 | Year | 02 | Month | 20 | Day |
Date of IRB
| 2015 | Year | 03 | Month | 01 | Day |
Anticipated trial start date
| 2015 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2016 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We take functional MRIs of patients with anti tumor agents, search the existences of cerebral vessel disorders.
Management information
Registered date
| 2015 | Year | 03 | Month | 08 | Day |
Last modified on
| 2022 | Year | 09 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019428
